
By: Andrew Leins
When Juan Casuso found out that his brother Gabriel had AIDS twenty one years ago he wanted to learn as much as he could about the disease. Juan looked up articles and spoke with the nurse who came to visit Gabriel almost every day. “She told us the things we needed to know, like what precautions to take,” said Casuso.
Gabriel was diagnosed with AIDS in 1986 and he participated in a clinical trial for AZT, a drug that was being introduced at the time to treat AIDS. Gabriel did not respond well to the drug, he became anemic and there was not much that could be done for him. “Eventually he came home so we could make him comfortable,” said Juan Casuso.
Casuso has worked at the University of Miami’s AIDS Clinical Research Unit (ACRU) for twenty years now, where he is the screening director. He decided to get into the field of AIDS research after his brother died, because he wanted to learn more about the disease and see if he could help.
Casuso reviews patients medical history and ascertains if they qualify for clinical trials at the research unit. He also sits down with the patients and talks to them about the disease. “The main thing is to give them information; there are still a lot of misconceptions out there,” said Casuso.
Patients at the ACRU undergo clinical trials for medications yet to be approved by the FDA or for trials involving new uses for existing approved drugs. They also receive medication while they are undergoing the trials. “For the patients its like a regular trip to the doctor’s office, the nurses attend to them and the doctor’s come to see them.”
Casuso, typically sees about three people per day for screening. He sees an ethnic mix of applicants. “I see people of all different races, ages, some older, some younger. Miami is an ethnically diverse place, so you get ethnically diverse patients.”
“When I started here, this was the only place in Florida where people could go for treatment.” Now, there are a lot resources for HIV/AIDS.”Casuso also got involved by going out to the community and trying to educate people about AIDS.
Juan believes that the tide in the fight against AIDS started to turn when it became apparent to politicians that the disease was affecting the general population and not just minorities.“There was a lot of misinformation, and people were not very receptive.” “I remember at the time that there was a big debate in the country about using the word ‘condom’ on television. You couldn’t say it. People didn’t want to talk about AIDS.”
As AIDS began to infect different and larger populations, more people where aware of the disease and perhaps knew someone who had it. “They were maybe not infected but they were affected by it,” said Casuso.
Even with today’s resources Casuso still witnesses a lot of public ignorance about AIDS.
“People tend to think that because there are drugs to treat the disease that they’ll be able to live with AIDS and be fine. But, there are side effects to the drugs and sometimes they don’t respond.”
“I have young people coming In often who are newly diagnosed, we aren’t doing enough to educate the public about prevention.” said Casuso.
Visit Andrew's Blog
When Juan Casuso found out that his brother Gabriel had AIDS twenty one years ago he wanted to learn as much as he could about the disease. Juan looked up articles and spoke with the nurse who came to visit Gabriel almost every day. “She told us the things we needed to know, like what precautions to take,” said Casuso.
Gabriel was diagnosed with AIDS in 1986 and he participated in a clinical trial for AZT, a drug that was being introduced at the time to treat AIDS. Gabriel did not respond well to the drug, he became anemic and there was not much that could be done for him. “Eventually he came home so we could make him comfortable,” said Juan Casuso.
Casuso has worked at the University of Miami’s AIDS Clinical Research Unit (ACRU) for twenty years now, where he is the screening director. He decided to get into the field of AIDS research after his brother died, because he wanted to learn more about the disease and see if he could help.
Casuso reviews patients medical history and ascertains if they qualify for clinical trials at the research unit. He also sits down with the patients and talks to them about the disease. “The main thing is to give them information; there are still a lot of misconceptions out there,” said Casuso.
Patients at the ACRU undergo clinical trials for medications yet to be approved by the FDA or for trials involving new uses for existing approved drugs. They also receive medication while they are undergoing the trials. “For the patients its like a regular trip to the doctor’s office, the nurses attend to them and the doctor’s come to see them.”
Casuso, typically sees about three people per day for screening. He sees an ethnic mix of applicants. “I see people of all different races, ages, some older, some younger. Miami is an ethnically diverse place, so you get ethnically diverse patients.”
“When I started here, this was the only place in Florida where people could go for treatment.” Now, there are a lot resources for HIV/AIDS.”Casuso also got involved by going out to the community and trying to educate people about AIDS.
Juan believes that the tide in the fight against AIDS started to turn when it became apparent to politicians that the disease was affecting the general population and not just minorities.“There was a lot of misinformation, and people were not very receptive.” “I remember at the time that there was a big debate in the country about using the word ‘condom’ on television. You couldn’t say it. People didn’t want to talk about AIDS.”
As AIDS began to infect different and larger populations, more people where aware of the disease and perhaps knew someone who had it. “They were maybe not infected but they were affected by it,” said Casuso.
Even with today’s resources Casuso still witnesses a lot of public ignorance about AIDS.
“People tend to think that because there are drugs to treat the disease that they’ll be able to live with AIDS and be fine. But, there are side effects to the drugs and sometimes they don’t respond.”
“I have young people coming In often who are newly diagnosed, we aren’t doing enough to educate the public about prevention.” said Casuso.
Visit Andrew's Blog









